부산대학교 도서관

Royal, Richard E.; Delpassand, Ebrahim S.; Shapiro, Suzanne E.; Fritsche, Herbert A., Jr; Vassilopoulou-Sellin, Rena; Sherman, Steven I.; Gagel, Robert F.; Evans, Douglas B.; Lee, Jeffrey E.

Surgery. Dec 01, 2002 132(6):968-975

Dackiw, Alan P. B.; Sussman, Jeffrey J.; Fritsche, Herbert A., Jr; Delpassand, Ebrahim S.; Stanford, Pam; Hoff, Ana; Gagel, Robert F.; Evans, Douglas B.; Lee, Jeffrey E.

Archives of Surgery. May 01, 2000 135(5):550-557

Calais J; Gafita A; Ahmanson Translational Theranostics Division, Department of Molecular & Medical Pharmacology, University of California Los Angeles, Los Angeles, California.; Eiber M; Ahmanson Translational Theranostics Division, Department of Molecular & Medical Pharmacology, University of California Los Angeles, Los Angeles, California.; Department of Nuclear Medicine, Technical University Munich, Klinikum rechts der Isar, Munich, Germany.; Armstrong WR; Ahmanson Translational Theranostics Division, Department of Molecular & Medical Pharmacology, University of California Los Angeles, Los Angeles, California.; Gartmann J; Ahmanson Translational Theranostics Division, Department of Molecular & Medical Pharmacology, University of California Los Angeles, Los Angeles, California.; Thin P; Ahmanson Translational Theranostics Division, Department of Molecular & Medical Pharmacology, University of California Los Angeles, Los Angeles, California.; Nguyen K; Ahmanson Translational Theranostics Division, Department of Molecular & Medical Pharmacology, University of California Los Angeles, Los Angeles, California.; Lok V; Ahmanson Translational Theranostics Division, Department of Molecular & Medical Pharmacology, University of California Los Angeles, Los Angeles, California.; Gosa L; Ahmanson Translational Theranostics Division, Department of Molecular & Medical Pharmacology, University of California Los Angeles, Los Angeles, California.; Grogan T; Department of Medicine Statistics Core, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, California.; Esfandiari R; Excel Diagnostics and Nuclear Oncology Center, Houston, Texas.; Allen-Auerbach M; Ahmanson Translational Theranostics Division, Department of Molecular & Medical Pharmacology, University of California Los Angeles, Los Angeles, California.; Institute of Urologic Oncology, University of California Los Angeles, Los Angeles, California.; Jonsson Comprehensive Cancer Center, University of California Los Angeles, Los Angeles, California.; Quon A; Ahmanson Translational Theranostics Division, Department of Molecular & Medical Pharmacology, University of California Los Angeles, Los Angeles, California.; Institute of Urologic Oncology, University of California Los Angeles, Los Angeles, California.; Jonsson Comprehensive Cancer Center, University of California Los Angeles, Los Angeles, California.; Bahri S; Ahmanson Translational Theranostics Division, Department of Molecular & Medical Pharmacology, University of California Los Angeles, Los Angeles, California.; Institute of Urologic Oncology, University of California Los Angeles, Los Angeles, California.; Jonsson Comprehensive Cancer Center, University of California Los Angeles, Los Angeles, California.; Gupta P; Ahmanson Translational Theranostics Division, Department of Molecular & Medical Pharmacology, University of California Los Angeles, Los Angeles, California.; Gardner L; Ahmanson Translational Theranostics Division, Department of Molecular & Medical Pharmacology, University of California Los Angeles, Los Angeles, California.; Ranganathan D; RadioMedix, Inc., Houston, Texas; and.; Slavik R; Ahmanson Translational Theranostics Division, Department of Molecular & Medical Pharmacology, University of California Los Angeles, Los Angeles, California.; Dahlbom M; Ahmanson Translational Theranostics Division, Department of Molecular & Medical Pharmacology, University of California Los Angeles, Los Angeles, California.; Physics & Biology in Medicine Interdepartmental Graduate Program, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, California.; Herrmann K; Ahmanson Translational Theranostics Division, Department of Molecular & Medical Pharmacology, University of California Los Angeles, Los Angeles, California.; Department of Nuclear Medicine, University of Duisburg-Essen and German Cancer Consortium (DKTK)-University Hospital Essen, Essen, Germany.; Delpassand E; Excel Diagnostics and Nuclear Oncology Center, Houston, Texas.; RadioMedix, Inc., Houston, Texas; and.; Fendler WP; Ahmanson Translational Theranostics Division, Department of Molecular & Medical Pharmacology, University of California Los Angeles, Los Angeles, California.; Department of Nuclear Medicine, University of Duisburg-Essen and German Cancer Consortium (DKTK)-University Hospital Essen, Essen, Germany.; Czernin J; Ahmanson Translational Theranostics Division, Department of Molecular & Medical Pharmacology, University of California Los Angeles, Los Angeles, California.; Institute of Urologic Oncology, University of California Los Angeles, Los Angeles, California.; Jonsson Comprehensive Cancer Center, University of California Los Angeles, Los Angeles, California.

Publisher: Society of Nuclear Medicine Country of Publication: United States NLM ID: 0217410 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1535-5667 (Electronic) Linking ISSN: 01615505 NLM ISO Abbreviation: J Nucl Med Subsets: MEDLINE

Calais J; Czernin J; Thin P; Ahmanson Translational Theranostics Division, Department of Molecular & Medical Pharmacology, University of California Los Angeles, Los Angeles, California.; Gartmann J; Ahmanson Translational Theranostics Division, Department of Molecular & Medical Pharmacology, University of California Los Angeles, Los Angeles, California.; Nguyen K; Ahmanson Translational Theranostics Division, Department of Molecular & Medical Pharmacology, University of California Los Angeles, Los Angeles, California.; Armstrong WR; Ahmanson Translational Theranostics Division, Department of Molecular & Medical Pharmacology, University of California Los Angeles, Los Angeles, California.; Allen-Auerbach M; Quon A; Bahri S; Gupta P; Ahmanson Translational Theranostics Division, Department of Molecular & Medical Pharmacology, University of California Los Angeles, Los Angeles, California.; Gardner L; Ahmanson Translational Theranostics Division, Department of Molecular & Medical Pharmacology, University of California Los Angeles, Los Angeles, California.; Dahlbom M; Ahmanson Translational Theranostics Division, Department of Molecular & Medical Pharmacology, University of California Los Angeles, Los Angeles, California.; He B; Advanced Accelerator Applications, a Novartis Company, Geneva, Switzerland.; Esfandiari R; Excel Diagnostics and Nuclear Oncology Center, Houston, Texas.; Ranganathan D; RadioMedix, Inc., Houston, Texas.; Herrmann K; Department of Nuclear Medicine, University of Duisburg-Essen and German Cancer Consortium (DKTK)-University Hospital Essen, Essen, Germany; and.; Eiber M; Department of Nuclear Medicine, Technical University Munich, Klinikum rechts der Isar, Munich, Germany.; Fendler WP; Department of Nuclear Medicine, University of Duisburg-Essen and German Cancer Consortium (DKTK)-University Hospital Essen, Essen, Germany; and.; Delpassand E; Excel Diagnostics and Nuclear Oncology Center, Houston, Texas.; RadioMedix, Inc., Houston, Texas.

Publisher: Society of Nuclear Medicine Country of Publication: United States NLM ID: 0217410 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1535-5667 (Electronic) Linking ISSN: 01615505 NLM ISO Abbreviation: J Nucl Med Subsets: MEDLINE

Gaber, A.M.; Núñez, R.; Delpassand, E.

In: Egyptian Journal of Radiology and Nuclear Medicine. (Egyptian Journal of Radiology and Nuclear Medicine, December 2021, 52(1))

Ruszniewski, P.; Strosberg, J.; Kunz, P.L.; Hendifar, A.; Yao, J.; Bushnel, D.; Kulke, M.H.; Baum, R.P.; Caplin, M.; Delpassand, E.; Hobday, T.; Verslype, C.; Benson, A.; Polack, B.; Beilei, H.; Santaro, P.; Krenning, E.

In Médecine Nucléaire March-April 2020 44(2):96-97

Strosberg J; Gastrointestinal Department/Neuroendocrine Tumor Division, Moffitt Cancer Center, Tampa, FL, USA. jonathan.strosberg@moffitt.org.; Kunz PL; Department of Medicine - Med/Oncology, Stanford University Medical Center, Stanford, CA, USA.; Hendifar A; Department of Internal Medicine/Hematology/Oncology, Cedars Sinai Medical Center, Los Angeles, CA, USA.; Yao J; Department of Gastrointestinal Medicinal Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Bushnell D; Department of Radiology, The University of Iowa, Iowa City, IA, USA.; Kulke MH; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Baum RP; Department of Nuclear Medicine, Zentralklinik Bad Berka, Bad Berka, Germany.; Caplin M; Department of Gastroenterology and Tumour Neuroendocrinology, Royal Free Hospital, London, UK.; Ruszniewski P; Division of Gastroenterology and Pancreatology, Hôpital Beaujon, Clichy, France.; Delpassand E; Department of Clinical Nuclear Medicine, Excel Diagnostics Imaging Clinic, Houston, TX, USA.; Hobday T; Department of Oncology, Mayo Clinic College of Medicine, Rochester, MN, USA.; Verslype C; Department of Hepatology, University Hospitals and KU Leuven, Leuven, Belgium.; Benson A; Hematology Oncology Division, Robert H. Lurie Comprehensive Cancer Center, Chicago, IL, USA.; Srirajaskanthan R; Department of Gastroenterology and General Internal Medicine, King's College Hospital - NHS Foundation Trust, London, UK.; Pavel M; Division of Hepatology and Gastroenterology, Charite-Universitätsmedizin Berlin, Berlin, Germany.; Mora J; Department of Nuclear Medicine, Hospital Universitari de Bellvitge, Barcelona, Spain.; Berlin J; Department of Medicine, Vanderbilt University Medical Center, Nashville, TN, USA.; Grande E; Department of Medical Oncology, MD Anderson Cancer Center, Madrid, Spain.; Reed N; Department of Medical Oncology, Beatson Oncology Centre, Glasgow, UK.; Seregni E; Department of Nuclear Medicine Therapy and Endocrinology, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico Istituto Nazionale dei Tumori, Milan, Italy.; Paganelli G; Department of Medical Oncology, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS, Meldola, Italy.; Severi S; Department of Medical Oncology, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS, Meldola, Italy.; Morse M; Department of Surgery, Duke University Medical Center, Durham, NC, USA.; Metz DC; GI Division, Hospital of the University of Pennsylvania, Philadelphia, PA, USA.; Ansquer C; Nuclear Medicine Department, Hôtel Dieu, University Hospital, Nantes, France.; Courbon F; Medical Imaging, Oncology University Institut Claudius Regaud, Toulouse, France.; Al-Nahhas A; Division of Imaging and Interventional Radiology, Imperial College London, London, UK.; Baudin E; Department of Endocrine Oncology and Nuclear Medicine, Institut Gustave Roussy, Villejuif, France.; Giammarile F; Department of Nuclear Sciences and Applications, International Atomic Energy Agency, Vienna, Austria.; Taïeb D; Department of Nuclear Medicine, Hôpital de la Timone, Marseille, France.; Mittra E; Department of Nuclear Medicine, Oregon Health & Science University, Portland, OR, USA.; Wolin E; Department of Medicine, Hematology and Medical Oncology, Icahn School of Medicine at Mount Sinai, New York, NY, USA.; O'Dorisio TM; Department of Internal Medicine, The University of Iowa, Iowa City, IA, USA.; Lebtahi R; Department of Nuclear Medicine, Royal Free Hospital, London, UK.; Deroose CM; Nuclear Medicine Department, University Hospitals and KU Leuven, Leuven, Belgium.; Grana CM; Division of Nuclear Medicine, Istituto Europeo di Oncologia, Milan, Italy.; Bodei L; Department of Nuclear Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Öberg K; Department of Endocrine Oncology, Uppsala University Hospital, Uppsala, Sweden.; Polack BD; Department of Medical Information, Advanced Accelerator Applications, a Novartis Company, Geneva, Switzerland.; He B; Advanced Accelerator Applications, a Novartis Company, Geneva, Switzerland.; Mariani MF; Research and Development, Advanced Accelerator Applications, a Novartis Company, Geneva, Switzerland.; Gericke G; Research and Development, Advanced Accelerator Applications, a Novartis Company, Geneva, Switzerland.; Santoro P; Department of Clinical Development, Advanced Accelerator Applications, a Novartis Company, Geneva, Switzerland.; Erion JL; Advanced Accelerator Applications, a Novartis Company, Geneva, Switzerland.; Ravasi L; Research and Development, Advanced Accelerator Applications, a Novartis Company, Geneva, Switzerland.; Krenning E; Department of Nuclear Medicine, Cyclotron Rotterdam BV, Erasmus University Medical Center, Rotterdam, Netherlands.

Publisher: Springer-Verlag Berlin Country of Publication: Germany NLM ID: 101140988 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1619-7089 (Electronic) Linking ISSN: 16197070 NLM ISO Abbreviation: Eur J Nucl Med Mol Imaging Subsets: MEDLINE

Tworowska, I.; Stallons, T.; Delpassand, E.; Torgue, J.; Saidi, A.; Jurek, P.; Kiefer, G.; Rojas-Quijano, F.; Ghaly, M.; Frey, E.; Sgouros, G.

In Nuclear Medicine and Biology July 2019 72-73 Supplement 1:S19-S20

Tu, Shi-Ming; Millikan, Randall E; Mengistu, Bayabel; Delpassand, Ebrahim S; Amato, Robert J; Pagliaro, Lance C; Daliani, Danai; Papandreou, Christos N; Smith, Terry L; Kim, Jeri; Podoloff, Donald A; Logothetis, Christopher J

In The Lancet 2001 357(9253):336-341

Hansen, A. R.; Probst, S.; Tutrone, R. F.; Osman, M. M.; Delpassand, E. S.; Nordquist, L. T.; Viglianti, B. L.; Michalski, J. M.; Beauregard, J-M.; Oz, O. K.; Courtney, K.; Jensen, J.; Wu, W.; Fleshner, N.; Sartor, O.; Chi, K. N.; Tagawa, S. T.

ANNALS OF ONCOLOGY; SEP 2022, 33 7, pS1185-pS1185, 1p. Supplement: 7